Results 221 to 230 of about 2,710,187 (284)

Deconstructing the genitourinary syndrome of menopause

International Urogynecology Journal, 2017
The concept of genitourinary syndrome of menopause (GSM) was recently introduced and has been gaining widespread use. While some justifications for its introduction are straightforward, others may be questionable. Numerous unspecific symptoms and signs were included in the definition of the syndrome, but the minimum number required for diagnosis was ...
Pedro Vieira-Baptista, Claudia Marchitelli, Hope K. Haefner, Gilbert Donders, Faustino Pérez-López   +4 more
openaire   +4 more sources

Genitourinary Syndrome of Menopause in Cancer Survivors

Clinical Obstetrics & Gynecology, 2023
Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the ...
Catherine L, Dugan, Alisha A, Othieno, Mindy E, Goldman   +2 more
openaire   +2 more sources

Hormonal Medications for Genitourinary Syndrome of Menopause

Clinical Obstetrics & Gynecology, 2023
Genitourinary syndrome of menopause is a common, under-reported, and undertreated chronic progressive condition requiring long-term treatment. Hypoestrogenism in the urogenital tissues is associated with bothersome dyspareunia, vulvovaginal symptoms, overactive bladder, and frequent urinary tract infections. Vaginal hormone therapies, including vaginal
JoAnn V, Pinkerton, Monique H, Vaughan, Andrew M, Kaunitz   +2 more
openaire   +2 more sources

Genitourinary Syndrome of Menopause: Prevalence and Predictors

Clinical Obstetrics & Gynecology, 2023
The genitourinary syndrome of menopause (GSM) has been proposed as a diagnosis by a consensus of clinicians and investigators. Our purpose for this paper is to review extant evidence about: 1) the breadth of symptoms and symptom clusters as related to the syndrome; 2) the prevalence of GSM (includes vulvar and vaginal atrophy); 3) factors that are ...
NANCY F. WOODS, JOAN F. SHAVER, JUDITH A. BERG   +2 more
openaire   +2 more sources

The role of microbiota in the management of genitourinary syndrome of menopause

Climacteric, 2023
It is estimated that the 25-50% of women who are reaching menopause every year report symptoms related to the genitourinary syndrome of menopause (GSM). The symptoms are not due simply to lack of estrogen. One possible contributing cause of symptoms is the vaginal microbiota.
Stabile, G, Topouzova, G A, De Seta, F
openaire   +3 more sources

Fractional CO2 laser for genitourinary syndrome of menopause: evaluating the evidence.

Menopause
The fractionated CO2 laser has been marketed to women for a variety of gynecologic symptoms and conditions, including the genitourinary syndrome of menopause (GSM).
Jen Gunter
semanticscholar   +1 more source

Genitourinary Syndrome of Menopause

Clinical Obstetrics & Gynecology, 2018
Genitourinary syndrome of menopause (GSM) describes a collection of exam findings and bothersome symptoms associated with estrogen deficiency involving changes to the labia, introitus, clitoris, vagina, urethra, and bladder. Vulvovaginal atrophy is a component of GSM.
openaire   +2 more sources

A Dermatologist’s Approach to Genitourinary Syndrome of Menopause

Journal of Cutaneous Medicine and Surgery, 2017
Background: Genitourinary syndrome of menopause (GSM) is a debilitating condition caused by hypoestrogenism that presents with vaginal dryness and dyspareunia as well as other genital, sexual, and urinary symptoms. Previously known as atrophic vaginitis, the term GSM is now used.
Marlene Dytoc, Matthew Hum
openaire   +3 more sources

Laser Therapy for Genitourinary Syndrome of Menopause

Current Urology Reports, 2018
The purpose of this article is to review the available data regarding the application and therapeutic outcomes of laser therapy for the treatment of genitourinary syndrome of menopause (GSM).There have been several studies regarding the use of laser therapy for the treatment of GSM. Most of these studies show a trend toward safe and effective treatment
Sharon Y. Byun, Russell Terry, Tina O’Shea, Andrew Rabley, M. Louis Moy   +4 more
openaire   +3 more sources

Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause

Annals of Internal Medicine
BACKGROUND Postmenopausal women commonly experience vulvovaginal, urinary, and sexual symptoms associated with genitourinary syndrome of menopause (GSM).
Elisheva R. Danan, Catherine Sowerby, Kristen E Ullman, Kristine Ensrud, Mary L. Forte, Nicholas L. Zerzan, Maylen Anthony, Caleb Kalinowski, H. Abdi, Jessica K. Friedman, Adrienne Landsteiner, N. Greer, Rahel Nardos, Cynthia Fok, Philipp Dahm, Mary Butler, T. Wilt, Susan Diem   +17 more
semanticscholar   +1 more source